spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR004109 Peptidase S29, hepatitus C polyprotein NS3

Protein matchesHelp
UniProtKB
Matches:
5130 proteins
AccessionHelp IPR004109 Peptidase_S29
TypeHelp Domain
SignaturesHelp
InterPro RelationshipsHelp
Parent IPR009003 Serine/cysteine peptidase, trypsin-like
GO Term annotationHelp
Process GO:0006508 proteolysis
GO:0019087 transformation of host cell by virus
Function GO:0008236 serine-type peptidase activity
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold:

  • Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins.
  • Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule.

In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding.

Proteolytic enzymes that exploit serine in their catalytic activity are ubiquitous, being found in viruses, bacteria and eukaryotes [1]. They include a wide range of peptidase activity, including exopeptidase, endopeptidase, oligopeptidase and omega-peptidase activity. Over 20 families (denoted S1 - S66) of serine protease have been identified, these being grouped into clans on the basis of structural similarity and other functional evidence [1]. Structures are known for members of the clans and the structures indicate that some appear to be totally unrelated, suggesting different evolutionary origins for the serine peptidases [1].

Not withstanding their different evolutionary origins, there are similarities in the reaction mechanisms of several peptidases. Chymotrypsin, subtilisin and carboxypeptidase C have a catalytic triad of serine, aspartate and histidine in common: serine acts as a nucleophile, aspartate as an electrophile, and histidine as a base [1]. The geometric orientations of the catalytic residues are similar between families, despite different protein folds [1]. The linear arrangements of the catalytic residues commonly reflect clan relationships. For example the catalytic triad in the chymotrypsin clan (PA) is ordered HDS, but is ordered DHS in the subtilisin clan (SB) and SDH in the carboxypeptidase clan (SC) [1, 2].

This signature identifies the Hepatitis C virus NS3 protein as a serine protease which belongs to MEROPS peptidase family S29 (hepacivirin family, clan PA(S)), which has a trypsin-like fold. The non-structural (NS) protein NS3 is one of the NS proteins involved in replication of the HCV genome. The NS2 proteinase (IPR002518), a zinc-dependent enzyme, performs a single proteolytic cut to release the N terminus of NS3. The action of NS3 proteinase (NS3P), which resides in the N-terminal one-third of the NS3 protein, then yields all remaining non-structural proteins. The C-terminal two-thirds of the NS3 protein contain a helicase. The functional relationship between the proteinase and helicase domains is unknown. NS3 has a structural zinc-binding site and requires cofactor NS4. It has been suggested that the NS3 serine protease of hepatitus C is involved in cell transformation and that the ability to transform requires an active enzyme [3].

Structural linksHelp
SCOP: b.47.1.3
Database linksHelp
PANDIT: PF02907
MEROPS: S29
Pfam Clan: CL0124.11

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR004109 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O92972 Genome polyprotein

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR002521 Hepatitis C virus core protein
IPR007094 RNA-directed RNA polymerase, positive-strand RNA eukaryotic virus
IPR002522 Hepatitis C virus capsid protein
IPR002531 Hepatitis C virus non-structural protein E2/NS1
IPR002166 RNA dependent RNA polymerase, hepatitis C virus
IPR014021 Helicase, superfamily 1/2, ATP-binding domain
IPR004109 Peptidase S29, hepatitus C polyprotein NS3
IPR009003 Serine/cysteine peptidase, trypsin-like
IPR013192 Zinc finger, hepatitis C virus non-structural 5a-type
IPR013193 Hepatitis C virus non-structural 5a, region 1b
IPR002519 Hepatitis C virus envelope glycoprotein E1
IPR001650 DNA/RNA helicase, C-terminal
IPR002518 Peptidase C18, hepatitis C virus endopeptidase 2
IPR001490 Hepatitis C virus non-structural protein NS4b
IPR000745 Hepatitis C virus non-structural protein NS4a
IPR002868 Hepatitis C virus non-structural 5a protein
IPR014001 DEAD-like helicase, N-terminal
PDB Chain
CATH Domain
SWISS-MODEL
SCOP Domain

PublicationsHelp
1. Rawlings ND, Barrett AJ.
Families of serine peptidases.
Meth. Enzymol. 244 19-61 1994 [PubMed: 7845208]
http://dx.doi.org/10.1016/0076-6879(94)44004-2
2. Rawlings ND, Barrett AJ.
Evolutionary families of peptidases.
Biochem. J. 290 ( Pt 1) 205-18 1993 [PubMed: 8439290]
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=8439290&action=stream&blobtype=pdf
3. Zemel R, Gerechet S, Greif H, Bachmatove L, Birk Y, Golan-Goldhirsh A, Kunin M, Berdichevsky Y, Benhar I, Tur-Kaspa R.
Cell transformation induced by hepatitis C virus NS3 serine protease.
J. Viral Hepat. 8 96-102 2001 [PubMed: 11264729]
http://dx.doi.org/10.1046/j.1365-2893.2001.00283.x

Additional ReadingHelp
Arasappan A, Njoroge FG, Chen KX, Venkatraman S, Parekh TN, Gu H, Pichardo J, Butkiewicz N, Prongay A, Madison V, Girijavallabhan V.
P2-P4 macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease.
Bioorg. Med. Chem. Lett. 16 2006 3960-5 [PubMed: 16730985]
http://dx.doi.org/10.1016/j.bmcl.2006.05.022
Bogen SL, Ruan S, Liu R, Agrawal S, Pichardo J, Prongay A, Baroudy B, Saksena AK, Girijavallabhan V, Njoroge FG.
Depeptidization efforts on P3-P2' alpha-ketoamide inhibitors of HCV NS3-4A serine protease: effect on HCV replicon activity.
Bioorg. Med. Chem. Lett. 16 2006 1621-7 [PubMed: 16387495]
http://dx.doi.org/10.1016/j.bmcl.2005.12.013
Urbani A, Bianchi E, Narjes F, Tramontano A, De Francesco R, Steinkuhler C, Pessi A.
Substrate specificity of the hepatitis C virus serine protease NS3.
J. Biol. Chem. 272 1997 9204-9 [PubMed: 9083052]
http://dx.doi.org/10.1074/jbc.272.14.9204
Love RA, Parge HE, Wickersham JA, Hostomsky Z, Habuka N, Moomaw EW, Adachi T, Hostomska Z.
The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.
Cell 87 1996 331-42 [PubMed: 8861916]
http://dx.doi.org/10.1016/S0092-8674(00)81350-1
Venkatraman S, Njoroge FG, Wu W, Girijavallabhan V, Prongay AJ, Butkiewicz N, Pichardo J.
Novel inhibitors of hepatitis C NS3-NS4A serine protease derived from 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid.
Bioorg. Med. Chem. Lett. 16 2006 1628-32 [PubMed: 16413182]
http://dx.doi.org/10.1016/j.bmcl.2005.12.046
Yan Y, Li Y, Munshi S, Sardana V, Cole JL, Sardana M, Steinkuehler C, Tomei L, De Francesco R, Kuo LC, Chen Z.
Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
Protein Sci. 7 1998 837-47 [PubMed: 9568891]
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=9568891
Perni RB, Chandorkar G, Cottrell KM, Gates CA, Lin C, Lin K, Luong YP, Maxwell JP, Murcko MA, Pitlik J, Rao G, Schairer WC, Van Drie J, Wei Y.
Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics.
Bioorg. Med. Chem. Lett. 17 2007 3406-11 [PubMed: 17482818]
http://dx.doi.org/10.1016/j.bmcl.2007.03.090
Prongay AJ, Guo Z, Yao N, Pichardo J, Fischmann T, Strickland C, Myers J Jr, Weber PC, Beyer BM, Ingram R, Hong Z, Prosise WW, Ramanathan L, Taremi SS, Yarosh-Tomaine T, Zhang R, Senior M, Yang RS, Malcolm B, Arasappan A, Bennett F, Bogen SL, Chen K, Jao E, Liu YT, Lovey RG, Saksena AK, Venkatraman S, Girijavallabhan V, Njoroge FG, Madison V.
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization.
J. Med. Chem. 50 2007 2310-8 [PubMed: 17444623]
http://dx.doi.org/10.1021/jm060173k
spacer
spacer
InterPro 23.1